The global allergen-free food market is valued at US$ 50.80 Billion in 2026 and is forecast to reach US$ 80.51 Billion by 2033, expanding at a CAGR of 6.8%.
Two primary forces underpin allergen-free food market growth: the expansion of mandatory allergen disclosure obligations, including Natasha's Law (2021) in the UK and Japan's Consumer Affairs Agency 28-allergen standard implemented in 2023, and the documented rise in food allergy prevalence among children in high-income markets tracked by health authorities globally.
Gluten-Free Foods holds the largest share at 38.0% of the global allergen-free food market in 2026, a position sustained by the convergence of medically-mandated coeliac purchasing and mainstream lifestyle wellness adoption across retail.
North America leads the global allergen-free food market with a 39.0% revenue share in 2026, driven by the most comprehensive mandatory allergen labelling regime globally, spanning nine declared allergens under federal law, and the highest per-capita density of clinically diagnosed food allergy patients among major geographies.
The highest-return opportunity lies in institutional foodservice channel penetration, specifically K-12 school nutrition programmes and healthcare catering, where updated dietary accommodation mandates are generating procurement pull for certified allergen-free suppliers at volume scale.